Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Rechtman

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|August 8, 2025
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathwayAriel Rechtman, Omri Zveik, Lyne Shweiki, et al.
Glia|March 10, 2022
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cellsOmri Zveik, Nina Fainstein, Ariel Rechtman, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 26, 2023
Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple SclerosisShahar Kahila, Omri Zveik, Netta Levin, et al.
International Journal of Molecular Sciences|July 9, 2022
Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in AstrocytesOmri Zveik, Ariel Rechtman, Nitzan Haham, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosisLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Annals of Clinical and Translational Neurology|November 6, 2024
Subclinical imaging activity in multiple sclerosis patients during war-related psychological stressOmri Zveik, Tal Friedman-Korn, Ariel Rechtman, et al.
Frontiers in Neurology|April 11, 2022
Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease CourseAriel Rechtman, Livnat Brill, Omri Zveik, et al.
Annals of Neurology|March 4, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with OcrelizumabLivnat Brill, Catarina Raposo, Ariel Rechtman, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccineLivnat Brill, Ariel Rechtman, Alla Shifrin, et al.
Glia|August 23, 2023
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNSTal Ganz, Omri Zveik, Nina Fainstein, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|August 8, 2025
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathwayAriel Rechtman, Omri Zveik, Lyne Shweiki, et al.
Glia|March 10, 2022
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cellsOmri Zveik, Nina Fainstein, Ariel Rechtman, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 26, 2023
Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple SclerosisShahar Kahila, Omri Zveik, Netta Levin, et al.
International Journal of Molecular Sciences|July 9, 2022
Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in AstrocytesOmri Zveik, Ariel Rechtman, Nitzan Haham, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosisLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Annals of Clinical and Translational Neurology|November 6, 2024
Subclinical imaging activity in multiple sclerosis patients during war-related psychological stressOmri Zveik, Tal Friedman-Korn, Ariel Rechtman, et al.
Frontiers in Neurology|April 11, 2022
Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease CourseAriel Rechtman, Livnat Brill, Omri Zveik, et al.
Annals of Neurology|March 4, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with OcrelizumabLivnat Brill, Catarina Raposo, Ariel Rechtman, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccineLivnat Brill, Ariel Rechtman, Alla Shifrin, et al.
Glia|August 23, 2023
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNSTal Ganz, Omri Zveik, Nina Fainstein, et al.
Pageof 3